DEPTOR Antibodies

Santa Cruz Biotechnology features a diverse variety of DEPTOR Antibodies for research focused on understanding DEPTOR's role in cellular processes. DEPTOR Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DEPTOR, a negative regulator of the mTOR signaling pathway, plays a crucial role in cell growth, proliferation, and survival. Dysregulation of DEPTOR has been implicated in various diseases, including cancer and metabolic disorders, making it a significant target for therapeutic intervention. Research utilizing DEPTOR monoclonal antibodies enables detailed investigation of cellular signaling mechanisms and disease pathways. Scientists can explore DEPTOR's interaction with other proteins and its impact on cellular functions through multiple experimental approaches. Advanced research techniques supported by DEPTOR monoclonal antibodies allow for precise protein detection and localization studies. Understanding DEPTOR's regulatory mechanisms can reveal new therapeutic strategies for treating various diseases. Santa Cruz Biotechnology monoclonal antibodies for DEPTOR research support scientists worldwide in advancing our understanding of cellular signaling pathways and their role in human health and disease.